New York, July 18, 2018: The biomarkers market is segmented by product, by type, by application and by disease indication. By product type it consists of consumable, services and software. By segmentation it covers safety biomarker, efficacy biomarker and validation biomarker. The efficacy biomarker is further segmented into pharmacodynamics, predictive, prognostic and surrogate biomarkers. The biomarkers have different applications such as diagnostics development, drug discovery & development, personalized medicine and disease risk assessment. Under disease indication it contains cancer, cardiovascular disorders, neurological disorders and immunological disorders. The biomarkers market geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    Biomarkers are biological measures used to measure biological states such as blood pressure, cholesterol level and monitor and forecast health level of individual. Biomarkers are used in single or in combination to identify health or disease of individual. Different varieties of biomarkers are used currently for various applications. Every biological system consists of its own biomarkers. Some biomarkers are easy to use, measure and form part of routine medical examinations. Biomarkers are used to estimate health and disease of individual such as diabetes and cardiovascular. Biomarkers are used for detection, screening, diagnosis, treatment and monitoring of cancer.

    The Biomarkers market is expected to exceed more than US$ 60.0 billion by 2023 growing at around 13% CAGR.

    You Can Find Full Report @:  https://www.marketresearchengine.com/reportdetails/biomarkers-market

    The main driving factors for biomarkers market are increase in number of low cost for conducting clinical trials in developing countries. Rising healthcare expenditure and R&D funding are the major macro drivers of the market. The use of biomarkers in diagnostic process is increasing rapidly due to its more accurate results. The biomarkers also have some restraints such as it contain technical issues related to sample and storage. The testing cost of biomarkers is high. It contains high investment but relatively low cost and benefit ratio.

    This report provides:

    1) An overview of the global market for biomarkers and related technologies.

    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2023.

    3) Identifications of new market opportunities and targeted promotional plans for biomarkers.

    4) Discussion of research and development, and the demand for new products and new applications.

    5) Comprehensive company profiles of major players in the industry.

    REPORT SCOPE:                                                                   

    The scope of the report includes a detailed study of global and regional markets for various types of biomarkers with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include QIAGEN N.V. (Netherlands), PerkinElmer, Inc., Merck & Co, Inc., Bio-Rad Laboratories , Enzo Biochem , EKF Diagnostics Holdings plc , Meso Scale Diagnostics, LLC , Singulex, Inc. , BioSims Technologies , Cisbio Bioassays , and Signosis, Inc.. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The Biomarkers Market has been segmented as below:

    The Biomarkers Market is Segmented on the lines of Product Segment Analysis, Type Analysis, Application Analysis, Disease Indication Analysis and Regional Analysis. By Product Segment Analysis this market is segmented on the basis of Consumable, Services and Software. By Type Analysis this market is segmented on the basis of Safety biomarker, Efficacy biomarker and Validation biomarker.

    By Application Analysis this market is segmented on the basis of Diagnostics development, Drug discovery & development, Personalized medicine and Disease risk assessment. By Disease Indication Analysis this market is segmented on the basis of Cancer, Cardiovascular disorders, Neurological disorders and Immunological disorders. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

    Request Sample Report @:  https://www.marketresearchengine.com/reportdetails/biomarkers-market

     

    Table of Contents

    1 INTRODUCTION

    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Market Overview

    6 Biomarkers Market, By Product

    7 Biomarkers Market, By Type

    8 Biomarkers Market, By Application

    9 Biomarkers Market, By Disease Indication

    10 Biomarkers Market, By Region

    11 Competitive Landscape

    12 Company Profiles

    12.1 Qiagen N.V.

    12.2 Perkinelmer, Inc.

    12.3 Merck Millipore

    12.4 Bio-Rad Laboratories, Inc.

    12.5 Enzo Biochem, Inc.

    12.6 EKF Diagnostics Holdings, Inc.

    12.7 Meso Scale Diagnostics, LLC.

    12.8 Biosims Technologies Sas

    12.9 Cisbio Bioassays

    12.10 Signosis, Inc.

     

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

     

     

    Source: http://www.financeswire.com/biomarkers-market-to-touch-us-60-billion-by-2023